LBP AM SA trimmed its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 83.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 189,710 shares of the pharmacy operator's stock after selling 985,197 shares during the quarter. LBP AM SA's holdings in Walgreens Boots Alliance were worth $1,770,000 as of its most recent filing with the SEC.
Other hedge funds have also bought and sold shares of the company. Charles Schwab Investment Management Inc. increased its holdings in Walgreens Boots Alliance by 43.6% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator's stock valued at $98,284,000 after buying an additional 3,329,857 shares during the period. Swedbank AB increased its holdings in Walgreens Boots Alliance by 45.3% in the 4th quarter. Swedbank AB now owns 595,828 shares of the pharmacy operator's stock valued at $5,559,000 after buying an additional 185,762 shares during the period. PNC Financial Services Group Inc. increased its holdings in Walgreens Boots Alliance by 23.4% in the 3rd quarter. PNC Financial Services Group Inc. now owns 340,431 shares of the pharmacy operator's stock valued at $3,050,000 after buying an additional 64,586 shares during the period. Sasco Capital Inc. CT increased its holdings in Walgreens Boots Alliance by 13.6% in the 3rd quarter. Sasco Capital Inc. CT now owns 1,041,440 shares of the pharmacy operator's stock valued at $9,331,000 after buying an additional 124,950 shares during the period. Finally, Sunbelt Securities Inc. increased its holdings in Walgreens Boots Alliance by 82.8% in the 3rd quarter. Sunbelt Securities Inc. now owns 139,377 shares of the pharmacy operator's stock valued at $1,249,000 after buying an additional 63,149 shares during the period. 58.59% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
Several equities analysts have commented on WBA shares. Truist Financial decreased their target price on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating on the stock in a report on Friday, January 31st. Bank of America lifted their price target on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an "underperform" rating in a report on Monday, January 13th. Royal Bank of Canada lifted their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a "sector perform" rating in a report on Wednesday, January 15th. StockNews.com assumed coverage on shares of Walgreens Boots Alliance in a report on Tuesday. They set a "hold" rating on the stock. Finally, Evercore ISI lifted their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an "in-line" rating in a report on Monday, January 13th. Four investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $10.59.
Get Our Latest Research Report on WBA
Walgreens Boots Alliance Trading Down 0.4 %
Shares of NASDAQ WBA traded down $0.04 during midday trading on Thursday, reaching $11.12. The stock had a trading volume of 12,041,721 shares, compared to its average volume of 20,599,074. The firm has a market cap of $9.61 billion, a price-to-earnings ratio of -1.09, a price-to-earnings-growth ratio of 1.31 and a beta of 0.62. Walgreens Boots Alliance, Inc. has a twelve month low of $8.08 and a twelve month high of $22.05. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. The company's 50 day moving average price is $10.93 and its 200 day moving average price is $9.80.
Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last issued its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.38 by $0.13. The firm had revenue of $39.50 billion for the quarter, compared to the consensus estimate of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The company's revenue for the quarter was up 7.6% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.66 EPS. As a group, sell-side analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.
Walgreens Boots Alliance Profile
(
Free Report)
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Featured Stories

Before you consider Walgreens Boots Alliance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.
While Walgreens Boots Alliance currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.